soul trial oral semaglutide cardiovascular outcomes results 2024 2025 (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine Targeting the weight within: obesity

Weaning off a GLP-1

MemAID: memory advancement with intranasal insulinvs

Certain medications for conditions linked with Acid Reflux, Type 2 Diabetes and some Contraceptive pills

(April 8, 2025) As glucagon-like peptide 1 (GLP-1) prescription medications commonly used for diabetes management and weight loss continue to increase in popularity, some findings reveal side effects that could affect oral health

In case of any issues, contact us Email ID: [email protected] Phone Number: 0124-4166666 Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India 1927 2846.57 32% off 473 ml Liquid Save more with additional offers Get up to 75 cashback on a minimum order value (MOV) of 499 and above, valid once per customer

Key Benefits & Added Enhancements: GLP-1 Activation & Appetite Regulation:Berberine, EGCG (Green Tea 50%), CLA, Tesofensine, Chromium, and Cinnamon Extract stimulate GLP-1 release, regulate appetite, and improve glycemic control, supporting fat metabolism, satiety, and insulin efficiency